Biblio

Export 812 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is V  [Clear All Filters]
Journal Article
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J., “A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J., “A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
J. Krell-Roesch, Syrjanen, J. A., Bezold, J., Trautwein, S., Barisch-Fritz, B., Boes, K., Woll, A., Forzani, E., Kremers, W. K., Machulda, M. M., Mielke, M. M., Knopman, D. S., Petersen, R. C., Vassilaki, M., and Geda, Y. E., “Physical Activity and Trajectory of Cognitive Change in Older Persons: Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 79, no. 1, pp. 377-388, 2021.
R. Mercorio, Pergoli, L., Galimberti, D., Favero, C., Carugno, M., Valle, E. Dalla, Barretta, F., Cortini, F., Scarpini, E., Valentina, V. Bollati, and Pesatori, A. Cecilia, “PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.”, J Alzheimers Dis, vol. 65, no. 1, pp. 283-292, 2018.
R. Mercorio, Pergoli, L., Galimberti, D., Favero, C., Carugno, M., Valle, E. Dalla, Barretta, F., Cortini, F., Scarpini, E., Valentina, V. Bollati, and Pesatori, A. Cecilia, “PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.”, J Alzheimers Dis, vol. 65, no. 1, pp. 283-292, 2018.
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria.”, J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
S. Hilal, Akoudad, S., van Duijn, C. M., Niessen, W. J., Verbeek, M. M., Vanderstichele, H., Stoops, E., M Ikram, A., and Vernooij, M. W., “Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 977-987, 2017.
S. Hilal, Akoudad, S., van Duijn, C. M., Niessen, W. J., Verbeek, M. M., Vanderstichele, H., Stoops, E., M Ikram, A., and Vernooij, M. W., “Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 977-987, 2017.
S. Hilal, Akoudad, S., van Duijn, C. M., Niessen, W. J., Verbeek, M. M., Vanderstichele, H., Stoops, E., M Ikram, A., and Vernooij, M. W., “Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 977-987, 2017.
S. Hilal, Akoudad, S., van Duijn, C. M., Niessen, W. J., Verbeek, M. M., Vanderstichele, H., Stoops, E., M Ikram, A., and Vernooij, M. W., “Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 977-987, 2017.
E. R. McGrath, Himali, J. J., Levy, D., Yang, Q., DeCarli, C. S., Courchesne, P., Satizabal, C. L., Finney, R., Vasan, R. S., Beiser, A. S., and Seshadri, S., “Plasma EFEMP1 Is Associated with Brain Aging and Dementia: The Framingham Heart Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 1657-1666, 2021.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., “Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., “Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”, J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
Sden Hoedt, Janssen, C. I. F., Astarita, G., Piomelli, D., Leijten, F. P. J., Crivelli, S. M., Verhoeven, A. J. M., De Vries, H. E., Walter, J., Martinez-Martinez, P., Sijbrands, E. J. G., Kiliaan, A. J., and Mulder, M. T., “Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels.”, J Alzheimers Dis, vol. 60, no. 3, pp. 769-781, 2017.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., “Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
C. Lomiguen, Vidal, L., Kozlowski, P., Prancan, A., and Stern, R., “Possible Role of Chitin-Like Proteins in the Etiology of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 2, pp. 439-444, 2018.
L. Bonanni, Franciotti, R., Martinotti, G., Vellante, F., Flacco, M. Elena, Di Giannantonio, M., Thomas, A., and Onofrj, M., “Post Traumatic Stress Disorder Heralding the Onset of Semantic Frontotemporal Dementia.”, J Alzheimers Dis, vol. 63, no. 1, pp. 203-215, 2018.
M. Bulk, Kenkhuis, B., van der Graaf, L. M., Goeman, J. J., Natté, R., and van der Weerd, L., “Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, 2018.
M. Bulk, Kenkhuis, B., van der Graaf, L. M., Goeman, J. J., Natté, R., and van der Weerd, L., “Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, 2018.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., “Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
T. Soares Martins, Magalhães, S., Rosa, I. Martins, Vogelgsang, J., Wiltfang, J., Delgadillo, I., Catita, J., Silva, O. A. B. da Cru, Nunes, A., and Henriques, A. Gabriela, “Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 391-405, 2020.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
S. J. B. Vos and Visser, P. Jelle, “Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.”, J Alzheimers Dis, vol. 64, no. s1, pp. S213-S227, 2018.

Pages